IMNM Crosses Above Average Analyst Target
February 07, 2024 at 06:57 AM EST
In recent trading, shares of Immunome Inc (IMNM) have crossed above the average analyst 12-month target price of $19.00, changing hands for $23.11/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..